149 related articles for article (PubMed ID: 24964187)
1. The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
Yates RL; Esiri MM; Palace J; Mittal A; DeLuca GC
Neuropathol Appl Neurobiol; 2015 Apr; 41(3):371-84. PubMed ID: 24964187
[TBL] [Abstract][Full Text] [Related]
2. Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
DeLuca GC; Alterman R; Martin JL; Mittal A; Blundell S; Bird S; Beale H; Hong LS; Esiri MM
Brain; 2013 Apr; 136(Pt 4):1025-34. PubMed ID: 23485854
[TBL] [Abstract][Full Text] [Related]
3. The influence of HLA-DRB1*15 on the relationship between microglia and neurons in multiple sclerosis normal appearing cortical grey matter.
Yates RL; Pansieri J; Li Q; Bell JS; Yee SA; Palace J; Esiri MM; DeLuca GC
Brain Pathol; 2022 Jul; 32(4):e13041. PubMed ID: 34904300
[TBL] [Abstract][Full Text] [Related]
4. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
[TBL] [Abstract][Full Text] [Related]
5. Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15.
Enz LS; Zeis T; Schmid D; Geier F; van der Meer F; Steiner G; Certa U; Binder TMC; Stadelmann C; Martin R; Schaeren-Wiemers N
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31882398
[TBL] [Abstract][Full Text] [Related]
6. The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
Balnyte R; Rastenyte D; Vaitkus A; Mickeviciene D; Skrodeniene E; Vitkauskiene A; Uloziene I
BMC Neurol; 2013 Jul; 13():77. PubMed ID: 23837503
[TBL] [Abstract][Full Text] [Related]
7.
Brownlee WJ; Tur C; Manole A; Eshaghi A; Prados F; Miszkiel KA; Wheeler-Kingshott CAG; Houlden H; Ciccarelli O
Mult Scler; 2023 Mar; 29(3):333-342. PubMed ID: 36398585
[TBL] [Abstract][Full Text] [Related]
8. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
[TBL] [Abstract][Full Text] [Related]
9. Month of birth, HLA-DRB1*15 locus and risk of multiple sclerosis in offspring.
Guijarro-Castro C; Sanchez-Zapardiel E; Munoz D; Fernandez O; Leyva L; Castro-Panete MJ; Picon-Munoz C; Talise M; Martinez-Feito A; Paz-Artal E
Rev Neurol; 2016 Sep; 63(5):201-5. PubMed ID: 27569565
[TBL] [Abstract][Full Text] [Related]
10. The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population.
Čierny D; Lehotský J; Kantorová E; Sivák Š; Javor J; Kurča E; Dobrota D; Michalik J
Neurol Res; 2018 Jul; 40(7):607-614. PubMed ID: 29619906
[TBL] [Abstract][Full Text] [Related]
11. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
12. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
[TBL] [Abstract][Full Text] [Related]
13. The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients.
Ghlichnia HA; Kollaee A; Gaffarpoor M; Movafagh A; Ghlichnia B; Zamani M
Acta Med Iran; 2014; 52(6):418-23. PubMed ID: 25130147
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB1*04:05 allele is associated with intracortical lesions on three-dimensional double inversion recovery images in Japanese patients with multiple sclerosis.
Shinoda K; Matsushita T; Nakamura Y; Masaki K; Yamasaki R; Yamaguchi H; Togao O; Hiwatashi A; Kira JI
Mult Scler; 2018 May; 24(6):710-720. PubMed ID: 28474969
[TBL] [Abstract][Full Text] [Related]
15. HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data.
Watanabe M; Nakamura Y; Sato S; Niino M; Fukaura H; Tanaka M; Ochi H; Kanda T; Takeshita Y; Yokota T; Nishida Y; Matsui M; Nagayama S; Kusunoki S; Miyamoto K; Mizuno M; Kawachi I; Saji E; Ohashi T; Shimohama S; Hisahara S; Nishiyama K; Iizuka T; Nakatsuji Y; Okuno T; Ochi K; Suzumura A; Yamamoto K; Kawano Y; Tsuji S; Hirata M; Sakate R; Kimura T; Shimizu Y; Nagaishi A; Okada K; Hayashi F; Sakoda A; Masaki K; Shinoda K; Isobe N; Matsushita T; Kira JI
Sci Rep; 2021 Jan; 11(1):607. PubMed ID: 33436735
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
17. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
[TBL] [Abstract][Full Text] [Related]
18. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
[TBL] [Abstract][Full Text] [Related]
19. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.
DeLuca GC; Ramagopalan SV; Herrera BM; Dyment DA; Lincoln MR; Montpetit A; Pugliatti M; Barnardo MC; Risch NJ; Sadovnick AD; Chao M; Sotgiu S; Hudson TJ; Ebers GC
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20896-901. PubMed ID: 18087043
[TBL] [Abstract][Full Text] [Related]
20. Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
Nolan D; Castley A; Tschochner M; James I; Qiu W; Sayer D; Christiansen FT; Witt C; Mastaglia F; Carroll W; Kermode A
Neurology; 2012 Aug; 79(6):538-46. PubMed ID: 22786591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
